Société de Therapeutique Marocaine S.A. (CBSE:SOT)

Morocco · Delayed Price · Currency is MAD

298.00

-9.50 (-3.09%)

At close: Oct 30, 2026

Market Cap	11.42B -11.9%
Revenue (ttm)	3.47B +14.3%
Net Income	406.90M +17.8%
EPS	7.59 -52.5%
Shares Out	38.31M
PE Ratio	39.28
Forward PE	n/a
Dividend	6.60 (2.22%)
Ex-Dividend Date	Jul 1, 2026

Volume	331
Open	307.50
Previous Close	307.50
Day's Range	296.15 - 308.00
52-Week Range	291.00 - 395.00
Beta	0.10
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 5, 2026

About CBSE:SOT

Société de Therapeutique Marocaine S.A., a pharmaceutical company, engages in the manufacturing of licensed medicines in Morocco. It offers products in various therapeutic areas, such as allergology, antibiotic, oncology, cardiology, dental, dermatology, endocrinology, gastroenterology, gynecology, ophthalmology, ENT, pediatric, pulmonology, reanimation, rheumatology, central nervous system (CNS), and urology, as well as antibiotics and generics. The company also provides its products in various forms, including tablets, capsules, pouches, syru... [Read more]

Industry Pharmaceutical Preparations

Founded 1976

Employees 1,404

Stock Exchange Casablanca Stock Exchange

Ticker Symbol SOT

Full Company Profile

Financial Performance

In 2025, CBSE:SOT's revenue was 3.23 billion, an increase of 14.55% compared to the previous year's 2.82 billion. Earnings were 385.53 million, an increase of 22.28%.

Financial Statements